Virginie Levrat

Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study

Nicolas Delanoy, Jean‐Marie Michot, Thibault Comont et al. · The Lancet Haematology · 2018 · 292 citations

Pharmacy, Hematology, Immunology +16

Genetic and phenotypic spectrum associated with IFIH1 gain‐of‐function

Gillian Rice, Sehoon Park, Francesco Gavazzi et al. · Human Mutation · 2020 · 113 citations · Full text

Life Sciences, Genetics, Immunology +17

Lung cancer trends and tumor characteristic changes over 20 years (2000–2020): Results of three French consecutive nationwide prospective cohorts’ studies

D. Debieuvre, Olivier Molinier, L. Falchero et al. · The Lancet Regional Health - Europe · 2022 · 76 citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Carglumic acid: an additional therapy in the treatment of organic acidurias with hyperammonemia?

Virginie Levrat, Isabelle Forest, Alain Fouilhoux et al. · Orphanet Journal of Rare Diseases · 2008 · 41 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +14

Betaine anhydrous in homocystinuria: results from the RoCH registry

Vassili Valayannopoulos, Manuel Schiff, Nathalie Guffon et al. · Orphanet Journal of Rare Diseases · 2019 · 28 citations · Full text

Pharmacy, Clinical Pharmacy, Pharmacotherapy +13